Projects per year
Personal profile
Education
- 2011 PhD, Institute of Clinical Pharmacy and Pharmaceutical Sciences , National Cheng Kung University
Experience
- 2011-2012, Postdoctoral Fellow/Department of Biochemistry and Molecular Biology, National Cheng Kung University
- 2012-present, Research Fellow/Antibody New Drug Development Center, National Cheng Kung University
- 2013-2015, Adjunct Assistant Professor/Department of Biochemistry and Molecular Biology, National Cheng Kung University
- 2015-present, Assistant Professor/Institute of Clinical Medicine, National Cheng Kung University
Research Interests
- Cytokine regulation
- Osteoimmunology
- New antibody drug development
Fingerprint Dive into the research topics where Yu-Hsiang Hsu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 5 Similar Profiles
Interleukins
Medicine & Life Sciences
Monoclonal Antibodies
Medicine & Life Sciences
Experimental Arthritis
Medicine & Life Sciences
Cytokines
Medicine & Life Sciences
Rheumatoid Arthritis
Medicine & Life Sciences
Osteolysis
Medicine & Life Sciences
interleukins
Agriculture & Biology
Inflammation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2006 2020
Il-20 in acute kidney injury: Role in pathogenesis and potential as a therapeutic target
Lin, T. Y. & Hsu, Y. H., 2020 Feb 1, In : International journal of molecular sciences. 21, 3, 1009.Research output: Contribution to journal › Review article
Open Access
kidney diseases
pathogenesis
kidneys
Acute Kidney Injury
Chronic Renal Insufficiency
IL-29 promoted obesity-induced inflammation and insulin resistance
Lin, T. Y., Chiu, C. J., Kuan, C. H., Chen, F. H., Shen, Y. C., Wu, C-H. & Hsu, Y-H., 2019 Jan 1, In : Cellular and Molecular Immunology.Research output: Contribution to journal › Article
Interleukins
Insulin Resistance
Obesity
Inflammation
Macrophages
1
Citation
(Scopus)
IL-20 bone diseases involvement and therapeutic target potential
Wang, H. H., Hsu, Y. H. & Chang, M. S., 2018 Apr 24, In : Journal of biomedical science. 25, 1, 38.Research output: Contribution to journal › Review article
Bone Diseases
Bone
Bone and Bones
Osteolysis
Osteogenesis
2
Citations
(Scopus)
The role of IL-20 in chronic kidney disease and diabetic nephropathy: Pathogenic and therapeutic implications
Chang, M-S. & Hsu, Y-H., 2018 Nov 1, In : Journal of Leukocyte Biology. 104, 5, p. 919-923 5 p.Research output: Contribution to journal › Review article
Diabetic Nephropathies
Chronic Renal Insufficiency
Renal Insufficiency
Diabetes Complications
Chemokines
1
Citation
(Scopus)
The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis
Huang, K., Hsu, Y., Chen, W., Tsai, H., Yan, J., Wang, J., Liu, W. & Lin, R., 2018 Dec 1, In : Journal of Inflammation. 15, 1Research output: Contribution to journal › Article
Thesis
The regulatory role of IL-29 on osteoblasts and osteoclasts
Author: 芳旭, 陳., 2018 Sep 1Supervisor: Hsu, Y. (Supervisor)
Student thesis: Master's Thesis
The role of IL-29 in adipocyte-macrophage crosstalk
Author: 恬毓, 林., 2017 Aug 18Supervisor: Hsu, Y. (Supervisor)
Student thesis: Master's Thesis